Gap-f Paediatric DTG Implementation Considerations for National Programmes

Overview

About the pDTG Task Team Of Gap-f ’s Product Access And Treatment Delivery (PATD) Working Group

The pDTG Task Team is a forum for coordination among partners involved in introduction of pDTG scored, dispersible tablets. The pDTG Task Team is a platform to share what partners are already doing, identify where work can complement each other and most importantly identify the gaps that need to be addressed and where GAP-f could help ensure that paediatric DTG can be scale-up as quickly as possible. Organizations participating in the pDTG Task Team include: Clinton Health Access Initiative (CHAI), Drugs for Neglected Diseases initiative (DNDi), Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), Global Fund to Fight AIDS, Tuberculosis and Malaria, International AIDS Society (IAS), International Center for AIDS Care and Treatment Programs (ICAP), Médecins Sans Frontières (MSF), Medicines Patent Pool (MPP), Paediatric-Adolescent Treatment Africa (PATA), UNAIDS, UNICEF, US Agency for International Development (USAID), US Centers for Disease Control and Prevention (US CDC), US Department of State, World Health Organization (WHO).

About the Global Accelerator For Paediatric Formulations (Gap-f )

GAP-f is a WHO Network hosted within the Research for Health Department in the Science Division and was created to respond to the paediatric treatment gap. Following the resolution at the 69th World Health Assembly on promoting innovation and access to quality, safe, efficacious, and affordable medicines for children, GAP-f was conceived to build on and formalize the model developed within the HIV community to provide a sustainable mechanism that ensures that safer, more effective, and more durable paediatric formulations are developed and made available to children against an accelerated timeline. More information is available at https://www.who.int/initiatives/gap-f.

Signatory: This brief was developed by the GAP-f pDTG Task Team
Website: https://www.who.int/initiatives/gap-f |Email: gap-f@who.int
Access the resource on the WHO website: https://www.who.int/publications/m/item/paediatric-dtg-implementation-considerations-for-national-programmes

Related Documents:

• Accelerating Patient Access to Optimal Antiretrovirals and Relevant Health Products (Optimal) Project
• Quantification and Budgeting for Rapid and Sustainable Access to New Pediatric Antiretroviral Therapies
• Accelerating Access to Optimal Child-Friendly Antiretroviral Formulations for Children Living with HIV